U.S. RESEARCH ROUNDUP-Amneal pharma, Aramark, Bluebird Bio

Emerson Electric Co

24/02/2025 07:19

Feb 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Amneal pharma, Aramark and Bluebird Bio, on Monday. 
    
    HIGHLIGHTS
     * Amneal pharma  AMRX.O : JP Morgan raises to overweight from neutral
     * Aramark  ARMK.N : Citigroup resumes coverage with buy rating; price target $48 
     * Bluebird Bio Inc  BLUE.O : JP Morgan raises to neutral from underweight 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in
alphabetical order.     
    
                 * Akamai Technologies Inc  AKAM.O : HSBC cuts target price to $115 from $121
 
                 * American Homes 4 Rent  AMH.N : RBC cuts target price to $39 from $40
 
                 * Amneal pharma  AMRX.O : JP Morgan raises to overweight from neutral
 
                 * Amneal pharma  AMRX.O : JP Morgan raises target price to $12 from $9
 
                 * Aramark  ARMK.N : Citigroup resumes coverage with buy rating; price target $48
 
                 * Bath & Body Works Inc  BBWI.N : Barclays raises target price to $43 from $34
 
                 * Bluebird Bio Inc  BLUE.O : JP Morgan raises to neutral from underweight
 
                 * Charles River Laboratories International Inc  CRL.N : TD Cowen cuts PT to $179 from
 $182
 
                 * Cheesecake Factory Inc  CAKE.O : JP Morgan raises target price to $55 from $45
 
                 * Conocophillips  COP.N : Jefferies cuts target price to $139 from $148
 
                 * Coty Inc  COTY.N : Piper Sandler cuts target price to $8 from $9
 
                 * Dropbox Inc  DBX.O : Jefferies cuts target price to $28 from $34
 
                 * Emerson Electric  EMR.N : HSBC cuts target price to $155 from $160
 
                 * Five9 Inc  FIVN.O : Jefferies raises target price to $45 from $40
 
                 * Kenvue Inc  KVUE.N : Piper Sandler raises target price to $27 from $24
 
                 * Kinsale Capital Group Inc  KNSL.N : JP Morgan cuts target price to $402 from $412
 
                 * Loar Holdings Inc  LOAR.N : RBC cuts target price to $92 from $100
 
                 * Occidental Petroleum Corp  OXY.N : Jefferies cuts target price to $52 from $54
 
                 * P&G  PG.N : Piper Sandler cuts target price to $172 from $173
 
                 * Rigel Pharmaceuticals Inc  RIGL.O : Jefferies raises target price to $23 from $14
 
                 * RingCentral Inc  RNG.N : Jefferies cuts target price to $32 from $38
 
                 * UTZ Brands Inc  UTZ.N : RBC cuts target price to $20 from $23
 
                 * Visa Inc  V.N : TD Cowen raises target price to $382 from $363
 
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))